WCK 4873 (INN: Nafithromycin): Structure-Activity relationship (SAR) identifying a novel lactone ketolide with activity against Streptococcus pneumoniae (SPN) and Streptococcus pyogenes (SPY)

[1]  Structural Diversification of 14-Membered Macrolides , 2022, Synfacts.

[2]  M. Gdaniec,et al.  An Approach to Modify 14-Membered Lactone Macrolide Antibiotic Scaffolds , 2022, The Journal of organic chemistry.

[3]  K. Rangappa,et al.  A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies. , 2021, European journal of medicinal chemistry.

[4]  R. Chavan,et al.  Preclinical Safety Evaluation of Nafithromycin (WCK 4873) with emphasis on liver safety in Rat and Dog. , 2021, Regulatory toxicology and pharmacology : RTP.

[5]  F. Bartl,et al.  Synthesis and antibacterial activity of new N-alkylammonium and carbonate-triazole derivatives within desosamine of 14- and 15-membered lactone macrolides. , 2020, ChemMedChem.

[6]  D. Gowda,et al.  Multi-targeted quinazolinone-Schiff's bases as potent bio-therapeutics , 2020 .

[7]  A. Janas,et al.  14- and 15-membered lactone macrolides and their analogues and hybrids: structure, molecular mechanism of action and biological activity. , 2019, European journal of medicinal chemistry.

[8]  P. Iwanowski,et al.  Safety, Tolerability, and Pharmacokinetics of Oral Nafithromycin (WCK 4873) after Single or Multiple Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects , 2019, Antimicrobial Agents and Chemotherapy.

[9]  H. K. Vivek,et al.  Aryl fluorosulfate analogues as potent antimicrobial agents: SAR, cytotoxicity and docking studies. , 2018, Bioorganic chemistry.

[10]  P. Lei,et al.  Synthesis and antibacterial activity of novel ketolides with 11,12-quinoylalkyl side chains. , 2018, Bioorganic & medicinal chemistry letters.

[11]  Hua-Li Qin,et al.  Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development! , 2018, Microbiological research.

[12]  Shivakumar,et al.  Effect of Low Charge and High Hydrophobicity on Antimicrobial Activity of the Quinazolinone-Peptide Conjugates , 2018, Russian Journal of Bioorganic Chemistry.

[13]  G. Dinos.  The macrolide antibiotic renaissance , 2017, British journal of pharmacology.

[14]  J. Karlowsky,et al.  Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia , 2016, Drugs.

[15]  Krystian Pyta,et al.  Regio- and Stereoselective Functionalization of 16-Membered Lactone Aglycone of Spiramycin via Cascade Strategy. , 2015, The Journal of organic chemistry.

[16]  M. Cushman,et al.  Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides. , 2013, European journal of medicinal chemistry.

[17]  Krystian Pyta,et al.  Transformation of josamycin in alkaline solution—intramolecular SN2 substitution or E1cB elimination and intramolecular Michael addition? , 2011 .

[18]  P. Przybylski.  Modifications and Biological Activity of Natural and Semisynthetic 16-Membered Macrolide Antibiotics , 2011 .

[19]  William M. Lee,et al.  Telithromycin‐associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases , 2009, Hepatology.

[20]  T. Kaneko,et al.  Novel tethers in ketolide antibiotics. , 2007, Bioorganic & medicinal chemistry letters.

[21]  S. Lociuro,et al.  A novel ketolide class: Synthesis and antibacterial activity of a lead compound. , 2007, Bioorganic & medicinal chemistry letters.

[22]  W. Mcmillen,et al.  Synthesis and antibacterial activity of C11, C12-cyclic urea analogues of ketolides. , 2007, Bioorganic & medicinal chemistry letters.

[23]  K. Bush,et al.  Synthesis and antibacterial activity of 3-keto-6-O-carbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives. , 2007, Bioorganic & medicinal chemistry letters.

[24]  L. Kellenberger,et al.  Antipropionibacterial Activity of BAL19403, a Novel Macrolide Antibiotic , 2007, Antimicrobial Agents and Chemotherapy.

[25]  T. Iwaki,et al.  A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: synthesis and structure-activity relationships. , 2006, Bioorganic & Medicinal Chemistry.

[26]  T. Iwaki,et al.  A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure-activity relationships. , 2005, Bioorganic & medicinal chemistry.

[27]  T. Yasukata,et al.  9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens. , 2005, Bioorganic & medicinal chemistry.

[28]  N. Soni,et al.  Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae. , 2005, Bioorganic & Medicinal Chemistry Letters.

[29]  Stuart Hayden,et al.  The synthesis of (9S)-9-alkyl-9-hydroxyerythromycin A derivatives and their ketolides , 2005 .

[30]  M. Jacobs,et al.  Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Telithromycin, Erythromycin, Azithromycin, and Clarithromycin against Haemophilus influenzae , 2004, Antimicrobial Agents and Chemotherapy.

[31]  I. Akritopoulou‐Zanze,et al.  Synthesis and antibacterial activity of novel bifunctional macrolides. , 2004, Bioorganic & medicinal chemistry letters.

[32]  L. Kellenberger,et al.  Novel ketolide antibiotics with a fused five-membered lactone ring--synthesis, physicochemical and antimicrobial properties. , 2004, Bioorganic & medicinal chemistry.

[33]  M. Mitten,et al.  Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides. , 2004, Bioorganic & medicinal chemistry letters.

[34]  G. Stone,et al.  Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens. , 2003, Journal of medicinal chemistry.

[35]  Suoming Zhang,et al.  Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. , 2001, Journal of medicinal chemistry.

[36]  T. Dougherty,et al.  ABT-773: a new ketolide antibiotic , 2001, Expert opinion on investigational drugs.

[37]  A. Bryskier.  Ketolides-telithromycin, an example of a new class of antibacterial agents. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  M. Mitten,et al.  Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. , 2000, Journal of medicinal chemistry.